Novavax to explore combined influenza/COVID-19 vaccine for use post pandemic

(Reuters) - Novavax Inc said on Tuesday it has set up a team of company veterans as it seeks U.S. regulatory approval for its seasonal influenza vaccine and to help develop a combined influenza/COVID-19 vaccine for use after the pandemic.

The flu vaccine, NanoFlu, met the primary and secondary goals in late-stage comparison study with Sanofi's influenza vaccine Fluzone Quadrivalent earlier in the year.

Novavax is among global drugmakers racing to develop a vaccine for COVID-19 and last month started a late-stage trial of its experimental vaccine, NVX‑CoV2373, in the United Kingdom.

NVX‑CoV2373 is also being tested in two ongoing mid-stage trials that began in August.

sonos sonos One (Gen 2) - Voice Controlled Smart Speaker with Amazon Alexa Built-in - Black read more

(Reporting By Mrinalika Roy in Bengaluru; Editing by Sriraj Kalluvila)

sonos sonos One (Gen 2) - Voice Controlled Smart Speaker with Amazon Alexa Built-in - Black read more

all right reserved for yahoo news

PREV Boy band BTS faces nationalistic anger in China over Korean War comment mogaznewsen
NEXT Troubled girl, 16, takes her own life on school grounds